Dandruff
📧 Sign up to get email alerts when something new happens for Dandruff.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-04Clinical Trial Update: Evaluation of the Benefits of Shampoo During 4 Weeks of Treatment and After 24 Weeks
A completed clinical trial evaluated the benefits of a Vichy shampoo for dandruff over four weeks of treatment and at 24 weeks.
-
CLINICAL_TRIALS trial_result · 2026-03-04Clinical Trial Update: Evaluation and Comparison of the Benefits of Routine vs Shampoo Alone During 4 Weeks Treatment and 12 Weeks Remanence
This clinical trial update reports completion of a study evaluating the benefits of a routine dandruff management approach versus shampoo-al…
-
CLINICAL_TRIALS trial_result · 2025-12-17Clinical Trial Update: Cleansing Device for the Treatment of Scalp and Hair Conditions [NA]
A University of Minnesota–sponsored clinical trial evaluating a cleansing device for dandruff, seborrheic dermatitis, and hair loss has been…
-
CLINICAL_TRIALS research · 2025-02-07Clinical Trial Update: Antidandruff Lotion Mediating Microbiome Rebalance [NA]
A sponsor-L'Oreal clinical trial evaluating an antidandruff lotion intended to rebalance the scalp microbiome in dandruff patients is curren…
-
CLINICAL_TRIALS trial_result · 2024-06-27Clinical Trial Update: Methodology Validation: Correlating Adherent Scalp Flaking Score (ASFS) With Phototrichogram for Scalp Dandruff Evaluation in Adult Subjects [NA]
A completed clinical trial validates a methodology by correlating Adherent Scalp Flaking Score (ASFS) with phototrichogram to evaluate scalp…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-05-19Clinical Trial Update: The Efficacy of Sodium Shale Oil Sulponate 1% Shampoo in the Treatment of Pityriasis Capitis [Phase 2]
A Phase 2 clinical trial evaluating the efficacy of a 1% shampoo containing sodium shale oil sulponate for dandruff has completed.
-
FDA approval · 2015-10-08FDA Approved: CICLOPIROX — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for Ciclopirox from Sun Pharmaceutical Industries, Inc., under the ANDA framework. The approval indi…